Gramicidin A: A New Mission for an Old Antibiotic

Gramicidin A (GA) is a channel-forming ionophore that renders biological membranes permeable to specific cations which disrupts cellular ionic homeostasis. It is a well-known antibiotic, however it’s potential as a therapeutic agent for cancer has not been widely evaluated. In two recently published studies, we showed that GA treatment is toxic to cell lines and tumor xenografts derived from renal cell carcinoma (RCC), a devastating disease that is highly resistant to conventional therapy. GA was found to possess the qualities of both a cytotoxic drug and a targeted angiogenesis inhibitor, and this combination significantly compromised RCC growth in vitro and in vivo. In this review, we summarize our recent research on GA, discuss the possible mechanisms whereby it exerts its anti-tumor effects, and share our perspectives on the future opportunities and challenges to the use of GA as a new anticancer agent.

[1]  Y. Reshetnyak,et al.  pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis , 2013, Scientific Reports.

[2]  Fengfei Wang,et al.  Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. , 2013, Current medicinal chemistry.

[3]  A. Rajasekaran,et al.  Gramicidin A Induces Metabolic Dysfunction and Energy Depletion Leading to Cell Death in Renal Cell Carcinoma Cells , 2013, Molecular Cancer Therapeutics.

[4]  Adam Huczyński.  Polyether Ionophores‐Promising Bioactive Molecules for Cancer Therapy , 2013 .

[5]  Cord Naujokat,et al.  Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.

[6]  B. Verdoodt,et al.  Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species , 2012, PloS one.

[7]  Y. Antonenko,et al.  N-Terminally Glutamate-Substituted Analogue of Gramicidin A as Protonophore and Selective Mitochondrial Uncoupler , 2012, PloS one.

[8]  Bei Zhang,et al.  Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK , 2012, Tumor Biology.

[9]  P. A. Futreal,et al.  State of the Science: An Update on Renal Cell Carcinoma , 2012, Molecular Cancer Research.

[10]  V. Haase,et al.  Renal cancer: oxygen meets metabolism. , 2012, Experimental cell research.

[11]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[12]  Yau-Huei Wei,et al.  AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. , 2012, Biochimica et biophysica acta.

[13]  O. Kallioniemi,et al.  Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress , 2012, British Journal of Cancer.

[14]  F. Wang,et al.  Solubilized Gramicidin A as Potential Systemic Antibiotics , 2012, Chembiochem : a European journal of chemical biology.

[15]  Jun Yin,et al.  Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. , 2011, Cancer letters.

[16]  H. Lee,et al.  Cancer cells promote survival through depletion of the von Hippel–Lindau tumor suppressor by protein crosslinking , 2011, Oncogene.

[17]  Soon-Cheol Ahn,et al.  Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. , 2011, Biochemical and biophysical research communications.

[18]  T. Kipps,et al.  Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells , 2011, Proceedings of the National Academy of Sciences.

[19]  G. Weinstein,et al.  Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas , 2011, Cell cycle.

[20]  M. Endres,et al.  Salinomycin induces calpain and cytochrome c-mediated neuronal cell death , 2011, Cell Death and Disease.

[21]  O. Kallioniemi,et al.  Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells , 2010, Molecular Cancer Therapeutics.

[22]  Emmanuel Ampofo,et al.  Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. , 2010, The international journal of biochemistry & cell biology.

[23]  D. Strumberg,et al.  Patient-based strategy for systemic treatment of metastatic renal cell carcinoma , 2010, Expert review of anticancer therapy.

[24]  G. Semenza.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.

[25]  G. Opelz,et al.  Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. , 2009, Biochemical and biophysical research communications.

[26]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[27]  M. Hamann,et al.  Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites , 2009, Expert opinion on drug discovery.

[28]  D. Seldin,et al.  Jade-1 inhibits Wnt signaling by ubiquitinating β-catenin and mediates Wnt pathway inhibition by pVHL , 2008, Nature Cell Biology.

[29]  S. McKenna,et al.  Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. , 2008, Biochemical Society transactions.

[30]  M. van Engeland,et al.  Genetics and epigenetics of renal cell cancer. , 2008, Biochimica et biophysica acta.

[31]  Amitabha Chattopadhyay,et al.  The gramicidin ion channel: a model membrane protein. , 2007, Biochimica et biophysica acta.

[32]  Won-Kyung Cho,et al.  E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis , 2006, Nature Medicine.

[33]  N. Rioux-Leclercq,et al.  Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  W. Zong,et al.  Alkylating DNA damage stimulates a regulated form of necrotic cell death. , 2004, Genes & development.

[35]  P. Hahnfeldt,et al.  Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. , 2003, Journal of theoretical biology.

[36]  Keunchil Park,et al.  Monensin‐mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis , 2002, International journal of cancer.

[37]  R. Conaway,et al.  A Molecular Basis for Stabilization of the von Hippel-Lindau (VHL) Tumor Suppressor Protein by Components of the VHL Ubiquitin Ligase* , 2002, The Journal of Biological Chemistry.

[38]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[39]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[40]  R. Burk,et al.  A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Coleman,et al.  The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity,against herpes simplex viruses type 1 and 2 in vitro , 1997, Archives of Virology.

[42]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[44]  B. Roelofsen,et al.  Growth inhibition of Plasmodium falciparum in in vitro cultures by selective action of tryptophan-N-formylated gramicidin incorporated in lipid vesicles. , 1991, Biochimica et biophysica acta.

[45]  S. Caplan.  Biological transport , 1979, Nature.

[46]  M. Rose,et al.  Stability of sodium and potassium complexes of valinomycin , 1974 .

[47]  H. Fraenkel-conrat,et al.  MODIFICATION OF GRAMICIDIN THROUGH REACTION WITH FORMALDEHYDE. , 1945, Science.

[48]  R. Dubos,et al.  THE PRODUCTION OF BACTERICIDAL SUBSTANCES BY AEROBIC SPORULATING BACILLI , 1941, The Journal of experimental medicine.

[49]  R. Dubos.  STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS , 1939, The Journal of experimental medicine.

[50]  S. Cosgrove,et al.  Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, seventh edition , 2017 .

[51]  P. Garnier,et al.  NAD+ as a metabolic link between DNA damage and cell death , 2005, Journal of neuroscience research.

[52]  B. Roelofsen,et al.  Effects of gramicidin and tryptophan-N-formylated gramicidin on the sodium and potassium content of human erythrocytes. , 1996, Molecular membrane biology.